Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives

Gastroenterology

Volumn 124, Issue 7, 2003, Pages 1980-1982

  Charlton, Michael ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; LACTALBUMIN; MALTODEXTRIN;

AMINO ACID METABOLISM; BACTERIAL PERITONITIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DIET THERAPY; EDITORIAL; HEALTH CARE COST; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER DISEASE; LONG TERM CARE; META ANALYSIS; NITROGEN BALANCE; NONHUMAN; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0038620375     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00550-X     Document Type: Editorial

References (22)

1. Ferenci P, Funovics J, Wewalka F. Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions [in German]. Chir Forum Exp Klin Forsch 1978;183-189
2. Kajiwara K, Okuno M, Kobayashi T, Honma N, Maki T, Kato M, Ohnishi H, Muto Y, Moriwaki H. Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci 1998;43: 1572-1579.
3. Ohashi H, Sukegawa E, Takami T, Yoshida T, Muto Y. Effects of supplementation with branched-chain amino acids on proteinnutritional status in rats treated by carbon tetrachloride [in Japanese]. Nippon Shokakibyo Gakkai Zasshi 1989;86:1645-1653.
4. Nakaya Y, Harada N, Kakui S, Okada K, Takahashi A, Inoi J, Ito S. Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture. J Gastroenterol 2002;37:531-536.
5. Watanabe A, Wakabayashi H, Kuwabara Y. Nutrient-induced thermogenesis and protein-sparing effect by rapid infusion of a branched chain-enriched amino acid solution to cirrhotic patients. J Med 1996;27:176-182.
6. Vilstrup H, Gluud C, Hardt F, Kristensen M, Kohler O, Melgaard B, Dejgaard A, Hansen BA, Krintel JJ, Schutten HJ. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. J Hepatol 1990;10:291-296.
7. Watanabe A, Shiota T, Okita M, Nagashima H. Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis. Acta Medica Okayama 1983;37:321-333.
8. Plauth M, Egberts EH, Hamster W, Torok M, Muller PH, Brand O, Furst P, Dolle W. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids: A double-blind placebo-controlled crossover study. J Hepatol 1993; 17:308-314.
9. Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario E, Fabbri A, Pisi E. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels. Hepatogastroenterology 1992;39:443-446.
10. Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, Martines D, Abbiati R. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group J Hepatol 1990;11:92-101.
11. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy: A double-blind placebo-controlled crossover study. Gastroenterology 1985;88:887-895.
12. Cerra FB, McMillen M, Angelico R, Cline B, Lyons J, Faulkenbach L, Paysinger J. Cirrhosis, encephalopathy, and improved results with metabolic support. Surgery 1983;94:612-619.
13. Sieg A, Walker S, Czygan P, Gartner U, Lanzinger-Rossnagel G, Stiehl A, Kommerell B. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver: A double blind crossover trial. Z Gastroenterol 1983;21:644-650.
14. McGhee A, Henderson JM, Millikan WJ Jr, Bleier JC, Vogel R, Kassouny M, Rudman D. Comparison of the effects of hepatic-aid and a casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg 1983; 197:288-293.
15. Michel H, Bories P, Aubin JP, Pomier-Layrargues G, Bauret P, Bellet-Herman H. Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture: A controlled study of 70 patients. Liver 1985;5:282-289.
16. Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. J Parenter Enteral Nutr 1996;20:159-164.
17. Naylor CD, O'Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: A meta-analysis. Gastroenterology 1989;97:1033-1042.
18. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguerico C, Rossi Fanelli F, Abbiati R, for the Italian BCCA Study Group. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind, randomized trial. Gastroenterology 2003;127:1792-1801.
19. Abad-Lacruz A, Cabre E, Gonzalez-Huix F, Fernandez-Banares F, Esteve M, Planas R, Llovet JM, Quer JC, Gassull MA. Routine tests of renal function, alcoholism, and nutrition improve the prognostic accuracy of Child-Pugh score in nonbleeding advanced cirrhotics. Am J Gastroenterol 1993;88:382-387.
20. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991;86:210-216.
21. Saito Y, Saito H, Nakamura M, Wakabayashi K, Takagi T, Ebinuma H, Ishii H. Effect of the molar ratio of branched-chain to aromatic amino acids on growth and albumin mRNA expression of human liver cancer cell lines in a serum-free medium. Nutr Cancer 2001;39:126-131.
22. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989;299:1202-1203.